Bevacizumab (璐濅紣鐝犲崟鎶?
浜у搧浠嬬粛
浜у搧鍚嶇О锛氱鐮旂骇 Bevacizumab ( 璐濅紣鐝犲崟鎶 ) 璐у彿锛歒R1001 鍝佺墝锛氬崱姊呭痉鐢熺墿 浠锋牸锛?700 淇濆瓨鏉′欢锛歋tored at -20掳C to -80掳C. 娴撳害锛?mg/ml 浜氬瀷锛欼gG1 Kappa 鎶椾綋鑻辨枃鍚嶏細12-IgG1, F(ab)-12 IgG1 搴旂敤鑼冨洿锛欶C, IP, ELISA, Neut, FuncS, IF, ICC 瑙勬牸锛?mg 浜у湴锛氬ぉ娲ュ競 鍏嬮殕鎬э細Monoclonal 闈剁偣锛歏EGFA[Homo sapiens] 鏁伴噺锛?9 鎶楀師鏉ユ簮锛欳HO Cells |
鍗℃寰风敓鐗╃鎶€锛堝ぉ娲ワ級鏈夐檺鍏徃
鐢佃瘽:鐐瑰嚮&鏌ョ湅 鑱旂郴浜国 寮犵粡鐞咟/span> 閭紪: 301700 鍦板潃: 澶╂触甯傛娓呭紑鍙戝尯鐣呮簮閬撳浗闄呬紒涓氱ぞ鍖 A5 鍙锋ゼ鍥涘眰
鍚屽搧鐗屼骇鍝侊細
鐩稿叧浜у搧锛欬/div>
|